At close: December 20 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 7 | 11 | 13 |
| Avg. Estimate | 31.3k | -- | 28.45k | 59.89M |
| Low Estimate | -- | -- | -- | 2.19M |
| High Estimate | 313k | -- | 313k | 249.9M |
| Year Ago Sales | -- | -- | -- | 28.45k |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 210,426.88% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RCKTW | -- | -- | -- | -- |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
BNTC Benitec Biopharma Inc.
11.41
-6.24%
IMU.AX Imugene Limited
0.0380
+5.56%
ARMP Armata Pharmaceuticals, Inc.
1.9500
-1.52%
LEXXW Lexaria Bioscience Corp.
0.7471
+14.94%
LXEO Lexeo Therapeutics, Inc.
6.28
+3.97%
GBIO Generation Bio Co.
1.1900
+10.19%
NLSPW NLS Pharmaceutics AG
0.0112
-41.05%
NRXS NeurAxis, Inc.
2.4000
0.00%
MOLN Molecular Partners AG
5.08
-1.93%
SBM.V Sirona Biochem Corp.
0.0800
+33.33%